Question 1

What are the top holdings in BIB?

Accepted Answer

ProShares Ultra Nasdaq Biotechnology (BIB) holds 271 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.

Question 2

How concentrated is BIB's portfolio?

Accepted Answer

Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review BIB's holdings table to analyze concentration risk.

Question 3

What is BIB's sector allocation?

Accepted Answer

The Sector Allocation chart shows how BIB distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.

Question 4

What countries does BIB invest in?

Accepted Answer

BIB's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.

Question 5

How diversified is BIB ETF?

Accepted Answer

BIB's diversification can be assessed by reviewing its 271 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.

Question 6

What are BIB's largest positions by weight?

Accepted Answer

BIB's largest positions are listed in the holdings table, sorted by portfolio weight percentage. The top holdings represent the securities with the highest allocation in the fund's portfolio composition.

#	Symbol	Name	Type	Weight
1	GILD	Gilead Sciences, Inc.	Stock	7.04%
2	AMGN	Amgen Inc.	Stock	6.32%
3	VRTX	Vertex Pharmaceuticals Incorporated	Stock	6.28%
4	REGN	Regeneron Pharmaceuticals, Inc	Stock	4.34%
5	ALNY	Alnylam Pharmaceuticals, Inc	Stock	2.93%
6	AZN	AstraZeneca PLC	Stock	2.63%
7	INSM	Insmed Incorporated	Stock	2.36%
8	ARGX	argenx NV ADR	Stock	1.52%
9	BIIB	Biogen Inc.	Stock	1.48%
10	UTHR	United Therapeutics Corporation	Stock	1.27%
11	ILMN	Illumina, Inc	Stock	1.17%
12	INCY	Incyte Corporation	Stock	1.10%
13	RPRX	Royalty Pharma plc	Stock	1.03%
14	RVMD	Revolution Medicines, Inc.	Stock	1.01%
15	VTRS	Viatris Inc.	Stock	0.90%
16	MEDP	Medpace Holdings, Inc	Stock	0.89%
17	MRNA	Moderna, Inc.	Stock	0.87%
18	NBIX	Neurocrine Biosciences, Inc	Stock	0.86%
19	ROIV	Roivant Sciences Ltd	Stock	0.85%
20	BBIO	BridgeBio Pharma, Inc	Stock	0.81%
21	ASND	Ascendis Pharma AS	Stock	0.76%
22	IONS	Ionis Pharmaceuticals, Inc.	Stock	0.74%
23	SNY	Sanofi	Stock	0.74%
24	SMMT	Summit Therapeutics PLC	Stock	0.74%
25	MDGL	Madrigal Pharmaceuticals, Inc	Stock	0.72%
26	GH	Guardant Health, Inc	Stock	0.72%
27	TEM	Tempus AI, Inc. Class A Common Stock	Stock	0.67%
28	EXEL	Exelixis, Inc	Stock	0.62%
29	B BGNE	BeiGene, Ltd	Stock	0.61%
30	BMRN	BioMarin Pharmaceutical Inc	Stock	0.58%
31	JAZZ	Jazz Pharmaceuticals plc	Stock	0.58%
32	ARWR	Arrowhead Pharmaceuticals, Inc	Stock	0.55%
33	BNTX	BioNTech SE	Stock	0.54%
34	RNA	Avidity Biosciences Inc	Stock	0.52%
35	CYTK	Cytokinetics, Incorporated	Stock	0.43%
36	RYTM	Rhythm Pharmaceuticals, Inc	Stock	0.43%
37	AXSM	Axsome Therapeutics, Inc	Stock	0.42%
38	HALO	Halozyme Therapeutics, Inc	Stock	0.41%
39	KRYS	Krystal Biotech, Inc	Stock	0.40%
40	NUVL	Nuvalent Inc	Stock	0.40%
41	KYMR	Kymera Therapeutics, Inc	Stock	0.36%
42	PTCT	PTC Therapeutics, Inc	Stock	0.34%
43	PTGX	Protagonist Therapeutics Inc	Stock	0.34%

BIB ETF Holdings: ProShares Ultra Nasdaq Biotechnology

Portfolio Allocations

Top 43 Holdings by Portfolio Weight